• 1
    Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol 2002; 29: 217.
  • 2
    Morinaga K, Kishimoto T, Sakatani M, Akira M, Yokoyama K, Sera Y. Asbestos-related lung cancer and mesothelioma in Japan. Indust Health 2001; 39: 6574.
  • 3
    Zellos LS, Sugerbaker DJ. Multimodality treatment of diffuse malignant pleural mesothelioma. Semin Oncol 2002; 29: 4150.
  • 4
    Gazdar AF, Butel JS, Carbone M. SV40 and human tumors: myth, association or causality? Nat Rev Cancer 2002; 2: 95764.
  • 5
    Carbone M, Stach R, DiResata I, Rizzo P. Simian virus 40 oncogenesis in hamsters. Dev Biol Stand 1998; 94: 2739.
  • 6
    Bocchetta M, Di Resata I, Powers A et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenecity. Proc Natl Acad Sci USA 2000; 97: 10 214–19.
  • 7
    Cacciotti P, Libener R, Betta P et al. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci USA 2001; 98: 12 032–7.
  • 8
    Carbone M, Rizzo P, Grimley PM et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 1997; 3: 90812.
  • 9
    De Luca A, Baldi A, Esposito V et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med 1997; 3: 91316.
  • 10
    Foddis R, De Reenzo A, Broccoli D et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002; 21: 143442.
  • 11
    Shivapurkar N, Wiethege T, Witsuba I et al. Presence of simian virus 40 sequences in malignant mesothelioma and mesothelial cell proliferations. J Cell Biochem 1999; 76: 1818.
  • 12
    Muratero C, Surentheran T, Rudd RM. Simian virus 40 and human pleural mesothelioma. Thorax 1999; 54: 601.
  • 13
    Hirvonen A, Mattson K, Karjalainen A et al. Simian virus 40 (SV40)-link DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol Carcin 1999; 26: 939.
  • 14
    Emri S, Kocagoz T, Olut A, Gungen Y, Mutti L, Baris Y. Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant mesothelioma in Turkey. Anticancer Res 2000; 20: 8914.
  • 15
    De Rienzo A, Tor M, Sterman DH, Aksoy F, Albelda SM, Testa JR. Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. J Cell Biochem 2002; 84: 4559.
  • 16
    Manfredi JJ, Dong J, Liu WJ et al. Evidence against a role for SV40 in human mesothelioma. Cancer Res 2005; 65: 26029.
  • 17
    WHO. Histological typing of lung cancer and pleural tumours. In: Travis WD, Colby TV, Corrin C, Shimosato Y, Brambilla E, eds, in collaboration with LH Sobin and pathologists from 14 countries. World Health Organization International Histological Classification of Tumours. Histological Typing of Lung and Pleural Tumours. 3rd edition. Tokyo: Springer, 1999: 713.
  • 18
    Huang H, Reis R, Yonekawa Y, Lopes JM, Kleihues P, Ohgaki H. Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol 1999; 9: 3342.
  • 19
    Toyooka KO, Toyooka S, Virmani AK et al. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 2001; 61: 455660.
  • 20
    Shivapurkar N, Takahashi T, Reddy J et al. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res 2004; 64: 375760.
  • 21
    Simsar A, Fetsch P, Bedrossian CWM, Ioffe OB, Abati A. Absence of SV-40 large T antigen (Tag) in malignant mesothelioma effusions: an immunocytochemical study. Diagn Cytopathol 2001; 25: 2037.
  • 22
    Kyoto Meeting on Poliomyelitis Eradication in the Western Pacific Region. The eradication of polio in Japan. In: World Health Organization, eds, Toward a Polio-Free World. Tokyo: Influx Com, 2000: 713.